Corrigendum to “Comparison of glucagons like peptide-1 receptor agonists and dipeptidyl peptide-4 inhibitors regarding cardiovascular safety and mortality in type 2 diabetes mellitus: A network meta-analysis” [Prim. Care Diabetes 15 (April (2)) (2021) 227–233]
The authors correct the title of their article which should read ‘Comparison of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptide-4 inhibitors regarding cardiovascular safety and mortality in type 2 diabetes mellitus: a network meta-analysis’
Source: Primary Care Diabetes - Category: Primary Care Authors: Jing Hu, Liyun Chen Tags: Corrigendum Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Primary Care | Sodium